Abstract
<h3>Background</h3> Corticosteroids (CS) remain the mainstay of therapy for childhood-onset systemic lupus erythematosus (cSLE) although there are no widely accepted dosing strategies of oral (PO CS) or intravenous CS (IV...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have